Quarterly report pursuant to sections 13 or 15(d)

Common Stock Equivalents (Details Textual)

v2.3.0.11
Common Stock Equivalents (Details Textual) (USD $)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2012
Jan. 31, 2012
Nov. 30, 2011
Oct. 31, 2011
Sep. 30, 2011
Aug. 31, 2011
Feb. 28, 2011
Aug. 31, 2010
Jul. 31, 2010
May 31, 2010
Apr. 30, 2010
Jun. 30, 2012
Dec. 31, 2009
Jun. 30, 2012
Dec. 31, 2011
Dec. 31, 2010
Aug. 25, 2010
Dec. 07, 2009
Common Stock Equivalents (Textual)                                    
Number of warrants issued 15,000 1,000,000 250,000   100,000   50,000   1,277,170       61,333          
Aggregate amount received from sale of warrants                   $ 57,500     $ 586,535     $ 75,839    
Exercise price $ 1.75 $ 1.75 $ 1.50 $ 1.00 $ 3.00   $ 20   $ 1.66   $ 3.0   $ 0.60          
Warrants cancelled                         16,667          
Sale of common stock for cash                                 $ 3.00 $ 3.00
Quantity                       11,928,169   11,928,169       446,665
Gain on the change in fair value                               225,579    
Loss on the change in fair value                         1,182,375     15,589    
Outstanding liability for the related derivative liability                         636,220     129,749    
Cancellation of outstanding warrants in exchange of shares of common stock                             565,000      
Remaining derivative liability associated warrants eliminated                             80,000      
Units issued under private placement                   3,834                
Company’s common stock exercisable price                   $ 30.00                
Remaining fair value of derivative liability                               17,500    
Increase in number of warrants due to sale of common stock               5,167,565     2,200,000   100,000     100,000    
Additional warrants issued to purchase common stock               10,000         500,000          
Exercise price of the additional issued warrants               $ 51.50         $ 0.60          
Exercise price of additional warrants issued               $ 15     $ 15              
Additional warrants issued to purchase share of company               1,033,433     440,000              
Company issued warrants one                     55,000              
Company issued warrants with exercise price one           200,000         5,000              
Warrants exercise price one           $ 2.50         $ 15.00              
Company issued warrants with exercise price two           500,000         50,000              
Warrants exercise price two           $ 5.00         $ 30.00              
Company issued warrants with exercise price three               500,000     5,000              
Warrants exercise price three           $ 7.50         $ 42.50              
Consulting services           81,633         32,355              
Share-based compensation               3,896,075     3,099,009              
Warrants exercise price four           $ 10.00   $ 10.00                    
Company issued warrants with exercise price four           500,000                        
Compensation cost     77,993       483,583   528,111     142,864   236,651        
Grant date fair value of warrants                           1,700,000        
Number of warrants with eliminated reset feature       7,467,165                            
Fair value of warrants, estimated on the date of grant, recorded as a derivative liability and related discount of short-term         20,751                          
Vesting period of warrants issued 3 years 3 years                                
Value of warrants on the date of the grant issued                           $ 26,000        
Expected volatility                           390.00%        
Discount rate                           2.11%        
Expected life (in years)                           3 years        
Dividend yield                           0.00%